000 01213 a2200361 4500
005 20250513113416.0
264 0 _c19970331
008 199703s 0 0 eng d
022 _a0959-8049
024 7 _a10.1016/s0959-8049(96)00356-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCuvier, C
245 0 0 _aVinorelbine in pregnancy.
_h[electronic resource]
260 _bEuropean journal of cancer (Oxford, England : 1990)
_cJan 1997
300 _a168-9 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents, Phytogenic
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMaternal-Fetal Exchange
650 0 4 _aPregnancy
650 0 4 _aPregnancy Complications, Neoplastic
_xdrug therapy
650 0 4 _aPregnancy Outcome
650 0 4 _aVinblastine
_xanalogs & derivatives
650 0 4 _aVinorelbine
700 1 _aEspie, M
700 1 _aExtra, J M
700 1 _aMarty, M
773 0 _tEuropean journal of cancer (Oxford, England : 1990)
_gvol. 33
_gno. 1
_gp. 168-9
856 4 0 _uhttps://doi.org/10.1016/s0959-8049(96)00356-5
_zAvailable from publisher's website
999 _c9059160
_d9059160